Trust Bridge Health™ is led by Antonio Carvalho, Managing Partner, who brings more than 25 years of international healthcare experience across pharmaceuticals, life sciences, and consumer healthcare. His career has included senior leadership roles, including Vice President and General Manager positions, at global organizations such as Novartis, Nycomed-Takeda, and DSM-Firmenich, with responsibilities spanning business development, licensing, M&A, commercial operations, and international expansion. Experience in healthcare investing, growth capital, and strategic transactions further complements this operational and industry background. Antonio is also an alumnus of Harvard Business School and Cardiff Business School.
The Swiss-based platform is supported by a lean, cross-functional network of professionals, advisors, and industry experts with experience spanning biotechnology, pharmaceuticals, clinical development, regulatory affairs, manufacturing, commercialization, healthcare investing, and strategic transactions.
Leveraging a Swiss-Asian network of pharmaceutical companies, investors, CROs, CDMOs, Key Opinion Leaders (KOLs), academic institutions, industry associations, and strategic partners, Trust Bridge Health brings together the expertise, relationships, and execution capabilities required to accelerate international growth, advance strategic partnerships, and maximize long-term asset and enterprise value.